Gabapentin and Chronic Post Surgical Pain
WithdrawnPhase 3NCT03867240
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The purpose of this study is to investigate the effect of a common pain medication (gabapentin) on chronic postsurgical pain in pediatric patients who require surgery for idiopathic scoliosis.
Study details
- Official title
- The Use of Perioperative Gabapentin in Adolescents Undergoing Posterior Spinal Fusion for Idiopathic Scoliosis to Prevent Chronic Postsurgical Pain, a Pilot Study.
- Conditions
- Pain, Postoperative
- Scoliosis Idiopathic
- Interventions
- Sponsor
- Emory University
- Start date
- 2019-06
- Primary completion
- 2022-09
- Sex
- All
- Age range
- from 10 Years to 18 Years
- Results posted
- No results posted in this snapshot
- Countries
- United States
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Be aged 10-18 years at the time of surgery * Have a diagnosis of idiopathic scoliosis and/or kyphosis * Be undergoing elective posterior spinal fusion * Have only mild systemic disease Exclusion Criteria: * A diagnosis of neuromuscular scoliosis and/or kyphosis * A diagnosis of chronic pain * Used opioids in the past 6 months * Developmental delay * Liver or kidney disease * Obstructive sleep apnea * Body mass index \>40 * Be pregnant or breastfeeding
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT03867240